Pfizers Quarterly Results Beat Expectations on Cancer, Heart Drugs
2026-08-10 09:17:28Pfizers Quarterly Results Beat Expectations on Cancer, Heart Drugs WSJ...
Read MorePfizer beats earnings estimates, targets $2.5 billion in additional cost cuts
2026-08-04 21:51:13Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts Reuters...
Read MorePfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis
2026-08-04 18:35:01Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis BusinessLine...
Read MorePfizers Quarterly Results Beat Expectations on Cancer, Heart Drugs
2026-08-04 17:44:00Pfizers Quarterly Results Beat Expectations on Cancer, Heart Drugs WSJ...
Read MorePfizer Raises Sales Guidance on High Demand for Older Drugs
2026-08-04 16:22:28Pfizer Raises Sales Guidance on High Demand for Older Drugs Bloomberg.com...
Read MorePfizer\'s oral drug restores skin pigmentation in late-stage vitiligo trials
2026-07-30 17:18:58Pfizer\'s oral drug restores skin pigmentation in late-stage vitiligo trials Reuters...
Read MorePfizer standalone net profit rises 6.63% in the June 2026 quarter
2026-07-28 14:58:18Pfizer standalone net profit rises 6.63% in the June 2026 quarter Business Standard...
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
04-Aug-2026 | Source : BSENewspaper Advertisement - Special Window for Re- lodgement of Transfer and Dematerialisation of Physical Securities.
Shareholder Meeting / Postal Ballot-Scrutinizers Report
29-Jul-2026 | Source : BSEPursuant to Regulation 44 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we submit herewith the consolidated Scrutinizers Report of the votes cast through remote e-voting and electronic polling process conducted during the 75th Annual General Meeting of the Company held on Tuesday July 28 2026 at 3.00 p.m. IST.
Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30 2026.
28-Jul-2026 | Source : BSEPursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the Unaudited Financial Results of the Company for the quarter ended June 30 2026 which were approved by the Board of Directors of the Company at their Meeting held today i.e. July 28 2026 that commenced at 11.30 a.m. and concluded at 1.35 p.m.
Corporate Actions
No Upcoming Board Meetings
Pfizer Ltd. has declared 750% dividend, ex-date: 17 Jul 26
No Splits history available
No Bonus history available
No Rights history available